This message was sent to ##Email##
|
|
|
|
|
SCAI
You’re invited to join the Interventional and Invasive Cardiovascular Community for the SCAI 2018 Scientific Sessions taking place April 25-28 in San Diego. Join 2,000 physicians, cardiovascular professionals, hospital administrators, academics, and industry professionals from across the world to share knowledge, clinical expertise, and the latest medical advances, all with one goal in mind — To Save and Enhance Lives!
Meet the SCAI 2018 Program Chairs
|
|
|
|
Ehtisham Mahmud, MD, FSCAI
Program Chair |
| Dennis Kim, MD, PhD, FSCAI
Congenital Heart Disease Program Chair
| 
Sunil Rao, MD, FSCAI
Program Co-Chair |
| Lee Benson, MD, FSCAI
Congenital Heart Disease Program Co-Chair
| 
Emmanouil Brilakis, MD, PhD, FSCAI
Program Co-Chair |
| John Moore, MD, FSCAI
Congenital Heart Disease Program Co-Chair
| 
|
|
|
SCAI
 Justin Zielke is a marketing professional with 15 years of experience in healthcare marketing, communications, and project management. In his new role, Mr. Zielke will oversee and implement marketing campaigns and communications to raise the value of the organization among SCAI members, interventional cardiologists, and healthcare professionals.
Justin holds a bachelor’s degree in psychology from the University of San Diego and a Master of Business Administration from the University of Maryland. He lives in Washington, DC, with his husband, Aaron.
TCTMD
Despite advances in stent technology, an analysis of U.S. Department of Veterans Affairs (VA) data indicates that rates of revascularization for in-stent restenosis may be on the rise.
Stephen W. Waldo, MD, the study’s lead author, told TCTMD the finding came as a surprise.
Another novel finding of the study, which was published online June 28 ahead of print in Catheterization and Cardiovascular Interventions, is that mortality was lower in those treated with a drug-eluting stent versus either plain old balloon angioplasty or a bare metal stent, something Waldo said hasn’t been demonstrated previously.
READ MORE
|
Promoted by
|
|
|
|
 |
The Cardiology Advisor
The U.S. Food and Drug Administration has approved a new pericardial aortic valve indicated for the replacement of native or prosthetic valves.
The Inspiris Resilia valve consists of “stented trileaflets” that are made from Resilia tissue, which is bovine pericardial tissue that has been treated with Edwards Integrity Preservation technology.
READ MORE
TCTMD
Women who have spontaneous coronary artery dissection (SCAD) during or shortly after pregnancy tend to have a more severe clinical presentation when compared with the wider SCAD population, with most cases occurring in the first postpartum month and especially in the first week, a new registry study shows.
Those findings confirm what had been suggested by clinical experience and prior studies based primarily on case reports and provide information that can be helpful for physicians involved in managing these types of patients, according to lead author Marysia Tweet, MD.
READ MORE
Cardiovascular Business
An experimental transcatheter device by Canada-based Neovasc, used to treat mitral regurgitation, was shown to be effective in treating a patient with several severe heart conditions. The Tiara, still an investigational device, was shown in a presentation by Shmuel Banai, MD, the director of interventional cardiology at the Tel Aviv Medical Center and Neovasc’s medical director, at this year’s Transcatheter Valve Therapies conference.
READ MORE
Advertisement
Pulsara
St. Elizabeth Healthcare, in Edgewood, Kentucky, serves a population of more than 400,000 across the Greater Cincinnati area, from Northern Kentucky to Indiana and Ohio. At St. Elizabeth, like most health systems in the U.S., there was no overarching way to organize all the different cardiac team members and stakeholders, which could cause treatment delays and disorganization. After adopting a set of recommended changes in the process of responding to heart attack patients including the implementation of Pulsara, the time from first medical contact to the moment of artery-opening treatment dropped 30 percent. See the full story here.
READ MORE
|
Healio
Patients with atrial fibrillation who received care from a cardiologist within 90 days after diagnosis had a decreased risk for stroke.
“The important message here is that getting early cardiology care was associated with early prescription of drugs specifically for preventing stroke,” Mintu Turakhia, MD, MAS, associate professor of cardiovascular medicine and director of research at the Center for Digital Health at Stanford University in California and director of cardiac electrophysiology at the VA Palo Alto Health Care System, said in a press release.
READ MORE
TCTMD
Faced with the prospect of financial penalties for higher than expected readmission rates, hospitals appear to have instituted changes in order to keep patients from returning to hospital. But according to researchers of a new study, changes likely prompted by the 2010 passage of the Affordable Care Act have not led to an increase in postdischarge mortality for patients with heart failure, acute myocardial infarction and pneumonia.
READ MORE
| Date |
Event |
Location |
| July 21-22, 2017 |
Complex Interventional Cardiovascular Therapy A Case Based Workshop- 11th Annual Meeting
|
San Francisco, CA
|
| July 28-29, 2017 |
SDCI: San Diego Cardiovascular Interventions, Robotics and CHIP
|
La Jolla, CA
|
| August 3-5, 2017 |
Cardiovascular Innovations 2017 |
Denver, CO
|
| August 18-20, 2017 |
ACC/SCAI Premier Interventional Cardiology Overview and Board Preparatory Course |
Washington, DC
|
| Dec. 9-12, 2017 |
SCAI 2017 Fall Fellows Courses |
Las Vegas, NV
|
For a complete list of job postings, click here.
To post your resume, click here.
|
Missed last week's issue? See which articles your colleagues read most.
|
|
Don't be left behind. Click here to see what else you missed.
|
|
|
|
|
|
|
|
|
|
7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063
|
